Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • General
  • News
  • Politics

U.S. House Of Representatives Passes Bill To Protect Access To Contraception

By Benzinga Newsdesk
July 21, 11:49 AM
-Bloomberg

AGRX

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Movers
  • News
  • Trading Ideas

Why Pool Corp Shares Are Diving Today

By Shivani Kumaresan
July 21, 11:49 AM
Pool Corp (NASDAQ:POOL) reported second-quarter FY22 sales growth of 15% year-on-year, to $2.06 billion, missing the consensus of $2.14 billion. EPS…

POOL

Read More
1 minute read
  • FDA
  • General
  • News
  • Politics

House Now Voting On Legislation That Would Enshrine Federal Protection Of Access To Contraceptives Without Government Restrictions Into Law

By Benzinga Newsdesk
July 21, 11:44 AM
https://twitter.com/CraigCaplan/status/1550143822281297920

AGRX

Read More
1 minute read
  • General
  • News
  • Politics

White House Says It Will Hold Briefing At 2 p.m. EST

By Benzinga Newsdesk
July 21, 11:17 AM
-Reuters

SPY

Read More
1 minute read
  • General
  • Government
  • News
  • Politics

Joe Biden Tests Positive For COVID-19: Here’s The Drug He’s Taking To Fight Symptoms

By AJ Fabino
July 21, 11:06 AM
President Joe Biden has tested positive for COVID-19, the White House said Thursday.

PFE

Read More
1 minute read
  • General
  • News
  • Politics

British Spy Chief Says Russia ‘About To Run Out Of Steam,’ Will Have To Pause, Giving Ukraine An Opportunity To Strike Back

By Benzinga Newsdesk
July 21, 10:59 AM
-Reuters

RSX

Read More
1 minute read
  • General
  • News
  • Politics

U.S. First Lady Jill Biden Tested Negative For COVID This Morning And Will Keep Her Full Schedule

By Benzinga Newsdesk
July 21, 10:55 AM
-Reuters

SPY

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

What’s Happening With Addex Therapeutics Shares Today

By Vandana Singh
July 21, 10:51 AM
Addex Therapeutics Ltd (NASDAQ:ADXN) shares are surging after reducing the nominal value of its issued, authorized, and conditional share…

ADXN

Read More
1 minute read
  • Eurozone
  • General
  • Government
  • Markets
  • News
  • Top Stories

European Central Bank Raises Interest Rates After 11 Years, By More Than Expected

By Vandana Singh
July 21, 10:45 AM
The European Central Bank (ECB) raised its benchmark deposit rate by 50 basis points to 0%, breaking its earlier guidance for…

FLEE

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Takeda Touts Encouraging Data For Hyqvia In Rare Nerve Inflammation Disorder

By Vandana Singh
July 21, 10:34 AM
Takeda Pharmaceutical Co Ltd’s (NYSE:TAK) Phase 3 trial (ADVANCE-1) of Hyqvia for the maintenance treatment of chronic inflammatory demyelinating…

TAK

Posts pagination

Previous 1 … 2,305 2,306 2,307 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service